Phase I Studies: On Time with Quality Data

July 24, 2024

Consistent Early Phase Milestone Achievement

Backed by select partnerships with Phase I Specialty Units and a tenured team, CRC consistently reaches milestones under tight clinical timelines in early phase studies. Learn how our strategic approach and robust collaboration led to dosing the last subject two weeks ahead of schedule while maintaining data quality in the case study below.

neural network
September 10, 2025
Why do neuropsychiatric trials fail? Experts Dr. Steve Brannan and Dr. David Walling share strategies to protect investments in neuropsychiatric drug development.
Jason Casarella
September 2, 2025
Experienced CRO executive joins Cognitive Research Corporation to expand partnerships and strengthen its position as a leading CRO for CNS clinical trials
psychedelic mushrooms
August 20, 2025
Psychedelic clinical research is advancing. Explore how trials with psilocybin, LSD, MDMA, and DMT are redefining protocols, standards, and future therapies.
Show More